ANI Pharmaceuticals Inc (ANIP)
Quick ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 144,861 | 144,982 | 240,110 | 228,597 | 221,121 | 193,078 | 161,707 | 67,757 | 48,228 | 56,281 | 63,385 | 76,911 | 100,300 | 15,254 | 24,261 | 25,073 | 7,864 | 17,900 | 27,702 | 20,414 |
| Short-term investments | US$ in thousands | 6,307 | 8,298 | 6,943 | 9,655 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 193,680 | 189,933 | 139,978 | 136,889 | 145,477 | 134,352 | 122,865 | 125,825 | 99,439 | 81,627 | 96,312 | 79,532 | 87,537 | 84,872 | 89,454 | 82,768 | 78,565 | 75,900 | 79,088 | 79,356 |
| Quick ratio | 0.78 | 0.81 | 1.76 | 1.74 | 1.52 | 1.44 | 1.32 | 0.54 | 0.49 | 0.69 | 0.66 | 0.97 | 1.15 | 0.18 | 0.27 | 0.30 | 0.10 | 0.24 | 0.35 | 0.26 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($144,861K
+ $6,307K
+ $—K)
÷ $193,680K
= 0.78
The quick ratio of ANI Pharmaceuticals Inc has shown fluctuations over the periods provided. It started at a low of 0.26 on March 31, 2020, and experienced ups and downs until December 31, 2021, where it dramatically improved to 1.15. This sharp increase indicated a significant improvement in the company's ability to meet its short-term obligations using its most liquid assets. The quick ratio remained strong and above 1 from March 31, 2022, to June 30, 2024, signaling that ANI Pharmaceuticals had a comfortable margin of safety in covering its current liabilities without relying on inventory. However, there was a slight decrease in the quick ratio to 0.78 by December 31, 2024. This decrease could indicate a potential strain on the company's liquidity position in meeting short-term obligations, although it's still above the threshold of 1, which is generally considered healthy. Overall, ANI Pharmaceuticals Inc maintained a relatively healthy quick ratio throughout the periods, with occasional fluctuations reflecting changes in its liquidity position.
Peer comparison
Dec 31, 2024